lOMoARcPSD|285 053 80 ii
lOMoARcPSD|285 053 80 ii
ii
ii
ATI Pharmacology Proctor 2025 Final Exam
ii ii ii ii ii
ii (Questions) Verified Correct Answers Latest Update
ii ii ii ii ii
Already Pass 100% Accurate
ii ii ii ii ii
ii
1. What iiis/are iithe iiaction(s) iiof iithe iidrug iimetformin? ii
a. Decreases iiHepatic iiglucose iiproduction iiand iiintestinal iiglucose iiabsorption
ii
b. Increases iisensitivity iito iiinsulin ii
c. Short iiterm iisedation ii
d. Both iiA iiand iiB ii- iid. iiBoth iiA iiand iiB ii
ii
When iiadministering iithe iidrug iisenna iito iia iipatient, iia iihealth iicare iiprovider iimust
iiinform ii
2. the iipatient iiof iiwhich iiof iithe iifollowing ii
a. This iidrug iiis iiintended iito iilower iiblood iipressure iiand iiis iibest iiused iiin
iicombination ii
with iiother iiantihypertensives ii
b. This iidrug iiis iinot iiintended iifor iilong iiterm iiuse ii
c. The iipatient iimust iilimit iihis/her iifiber iiintake ii
d. Advise iipatient iito iichange iipositions iislowly iito iilimit iithe iirisk iiof iiorthostatic
iihypotension ii- iib. iiThis iidrug iiis iinot iiintended iifor iilong iiterm iiuse ii
ii
3. When iigiving iidigoxin ii(Lanoxin) iito iia iipatient, iithe iihealth iicare iiprovider iinotices
iivarious iisigns iiand iisymptoms iiof iian iioverdose. iiThe iihealth iicare iiprovider iiknows
iito iigive iiwhich iiof iithe iifollowing iito iireverse iidigoxin iitoxicity ii
a. Naloxone ii
b. Vitamin iiK ii
c. Digibind ii
d. Fluemanzil ii- iic. iiDigibind ii
ii
While iiproviding iian iiAngiotensin-converting iienzyme ii(ACE) iiinhibitor, iithe iipatient
iiasks ii
4. what iithe iiaction iiof iithe iidrug iiis. iiAs iia iihealth iicare iiprovider, iiyou iiexplain iithat iithe
iiaction iiof iian iiACE iiinhibitor iiis ii
a. To iilower iiblood iipressure iiby iiblocking iithe iiconversion iiof iiangiotensin iiI ii
to iivasoconstrictor iiangiotensin iiII ii
b. To iiinhibit iireabsorption iiof iisodium iiback iiinto iithe iibody, iiultimately iiincreasing
iiurine iioutput iiand iilowering iiblood iipressure ii
c. To iidecrease iiheart iirate iiand iiblood iipressure iiby iicompeting iiwith iiBeta1 iiand ii
Beta2 iireceptors iiin iithe iiheart iiand iilungs ii
, lOMoARcPSD|285 053 80 ii
d. To iilower iiblood iiglucose iiby iistimulating iithe iirelease iiof iiinsulin ii- iia. iiTo iilower
iiblood iipressure iiby iiblocking iithe iiconversion iiof iiangiotensin iiI iito
iivasoconstrictor iiangiotensin iiII ii
ii
5. Which iiof iithe iifollowing iitypes iiof iiinsulin iiis ii"long-acting"? ii
a. Lispro ii(Humalog) ii
b. NPH ii(Humulin iiN) ii
c. Regular iiinsulin ii(Humulin iiR) ii
d. Glargine ii(Lantus) ii- iid. iiGlargine ii(Lantus) ii
6. What iiis iithe iitherapeutic iiuse iiof iimetformin? iiA. iiLower iiblood iipressure. ii
B. To iidiminish iiseizure iiactivity. ii
C. The iimaintenance iiof iia iiperson's iiblood iiglucose. ii
D. Increase iiheart iirate iiand iidecrease iigastrointestinal iisecretions. ii- iiC. iiThe
iimaintenance iiof iia iiperson's iiblood iiglucose. ii
ii
1. What iiis iithe iicorrect iidefinition iifor iiabsorption iiof iia iidrug? ii
A. Movement iiof iidrug iifrom iisite iiof iiadministration iito iivarious iitissues iiof iithe
iibody. ii
B. Describes iithe iiabsorption, iidistribution, iimetabolism ii& iiexcretion iiof iidrugs.
ii
C. These iitypes iiof iidrugs iican iibe iitaken iiover iithe iicounter. ii
D. This iiaddresses iihow iivarious iidrugs iiaffect iidifferent iiforms iiof iithe iibody ii-
iiA. iiMovement iiof iidrug iifrom iisite iiof iiadministration iito iivarious iitissues iiof
iithe iibody ii
ii
2. What iido iiyou iiassess iifor iiin iia iipatient iiwho iiis iion iiValproate? iiSelect iiall iithat
iiapply. ii
A. Suicidal iithoughts ii
B. Monitor iifor iiseizures. ii
C. Bipolar iidisorder. ii
D. Migraines. ii
E. Anorexia ii- iiA. iiSuicidal iithoughts ii
7. B. iiMonitor iifor iiseizures. iiC. iiBipolar iidisorder. iiE. iiMigraines. ii
ii
8. What iiis iitrue iiabout iifood iiand iidrug iiprecautions? iiSelect iiall iithat iiapply. ii
A. You iimust iilimit iicertain iitypes iiof iifood iior iiconcurrent
iiadministration iiof iicertain iitypes iiof iidrugs. ii
B. Certain iicombinations iiof iifood iiand iidrugs iican iicause iiadverse
iireactions. iiC. iiPrecautions iimay iirequire iilimiting iicertain iitypes iiof
iifood iior iiconcurring iidrugs iirather iithan iirestricting iithe iidrug iiitself. ii
C. When iione iidrug iichanges iithe iiway, iianother iidrug iiaffects iithat
iidrug. ii- iiA. iiYou iimust iilimit iicertain iitypes iiof iifood iior iiconcurrent
iiadministration iiof iicertain iitypes iiof iidrugs. ii
B. iiCertain iicombinations iiof iifood iiand iidrugs iican iicause iiadverse iireactions. iiC.
iiPrecautions iimay iirequire iilimiting iicertain iitypes iiof iifood iior iiconcurring iidrugs
iirather iithan iirestricting iithe iidrug iiitself. ii
ii
, lOMoARcPSD|285 053 80 ii
9. ACE iiInhibitors iiare iiused iiin iithe iitreatment iiof iiall iiEXCEPT: ii
a. Hypertension ii
b. Heart iiFailure ii
c. Hypotension ii
d. Diabetic iinephropathy ii- iic. iiHypotension ii
ii
10. Which iiof iithe iifollowing iiis iiused iito iitreat iimigraine iiheadaches? ii
a. Beta-blockers ii
b. Cholinesterase iiInhibitors ii
c. ACE iiinhibitors ii
d. iiAnti-epileptic iidrugs ii(AEDs) ii- iia. iiBeta-blockers ii
ii
11. When iiadministering iia iiSerotonin iiAntagonist iiit iiis iiimportant iito iimonitor iifor ii
a. Intake iiand iioutput ii
b. Mental iistatus iichanges ii
c. Respiratory iirate ii
d. Anorexia ii- iib. iiMental iistatus iichanges ii
ii
12. Which iiof iithe iifollowing iiis iithe iiantidote iifor iiHeparin? ii
a. Protamine iisulfate ii
b. Vitamin iiK ii
c. Naloxone ii
d. Toradol ii- iia. iiProtamine iisulfate ii
ii
13. A iipatient iihas iibeen iitaking iihydrocodone, iiand iiopioid iianalgesic iifor iitheir
iimoderate iipain, iiand iithey iihave iitaken iiover iitheir iiprescribed iidose. iiWhat iishould
iiyou iigive iias iithe iiantidote iiif iithey iiexperience iitoxicity? ii
A. Naloxone ii
B. N-acetylcysteine ii
C. Atropine ii
D. Digoxin iiimmune iiFab ii- iiA. iiNaloxone ii
ii
14.A iiA iipatient iiis iibeing iieducated iion iitaking iilevothyroxine, iia iidrug iiused iito
iibalance iithyroid iiactivity. iiWhat iishould iiyou iiinclude iiin iitheir iieducation? ii
A. Don't iibother iiyour iihealth iicare iiprofessionals iiif iiyou iiexperience
iiside iieffects ii
B. Take iithis iiat iithe iisame iitime iievery iiday ii
C. Thyroid iitests iiare iiunnecessary iiwhile iitaking iithis iidrug ii
D. It iiis iiokay iito iitake iithis iidrug iiif iiyou iihave iirecently iihad iia
iimyocardial iiinfarction ii- iiB. iiTake iithis iiat iithe iisame iitime iievery
iiday ii
ii
15.A iiA iipatient iistates iihe iiexperiences iianxiety iiand iihas iipanic iiattacks iiat iileast iionce
iia iiweek. iiWhat iimight iibe iihelpful iifor iithis iipatient? ii
A. Phenytoin ii(Dilantin) ii
B. Lithium ii
lOMoARcPSD|285 053 80 ii
ii
ii
ATI Pharmacology Proctor 2025 Final Exam
ii ii ii ii ii
ii (Questions) Verified Correct Answers Latest Update
ii ii ii ii ii
Already Pass 100% Accurate
ii ii ii ii ii
ii
1. What iiis/are iithe iiaction(s) iiof iithe iidrug iimetformin? ii
a. Decreases iiHepatic iiglucose iiproduction iiand iiintestinal iiglucose iiabsorption
ii
b. Increases iisensitivity iito iiinsulin ii
c. Short iiterm iisedation ii
d. Both iiA iiand iiB ii- iid. iiBoth iiA iiand iiB ii
ii
When iiadministering iithe iidrug iisenna iito iia iipatient, iia iihealth iicare iiprovider iimust
iiinform ii
2. the iipatient iiof iiwhich iiof iithe iifollowing ii
a. This iidrug iiis iiintended iito iilower iiblood iipressure iiand iiis iibest iiused iiin
iicombination ii
with iiother iiantihypertensives ii
b. This iidrug iiis iinot iiintended iifor iilong iiterm iiuse ii
c. The iipatient iimust iilimit iihis/her iifiber iiintake ii
d. Advise iipatient iito iichange iipositions iislowly iito iilimit iithe iirisk iiof iiorthostatic
iihypotension ii- iib. iiThis iidrug iiis iinot iiintended iifor iilong iiterm iiuse ii
ii
3. When iigiving iidigoxin ii(Lanoxin) iito iia iipatient, iithe iihealth iicare iiprovider iinotices
iivarious iisigns iiand iisymptoms iiof iian iioverdose. iiThe iihealth iicare iiprovider iiknows
iito iigive iiwhich iiof iithe iifollowing iito iireverse iidigoxin iitoxicity ii
a. Naloxone ii
b. Vitamin iiK ii
c. Digibind ii
d. Fluemanzil ii- iic. iiDigibind ii
ii
While iiproviding iian iiAngiotensin-converting iienzyme ii(ACE) iiinhibitor, iithe iipatient
iiasks ii
4. what iithe iiaction iiof iithe iidrug iiis. iiAs iia iihealth iicare iiprovider, iiyou iiexplain iithat iithe
iiaction iiof iian iiACE iiinhibitor iiis ii
a. To iilower iiblood iipressure iiby iiblocking iithe iiconversion iiof iiangiotensin iiI ii
to iivasoconstrictor iiangiotensin iiII ii
b. To iiinhibit iireabsorption iiof iisodium iiback iiinto iithe iibody, iiultimately iiincreasing
iiurine iioutput iiand iilowering iiblood iipressure ii
c. To iidecrease iiheart iirate iiand iiblood iipressure iiby iicompeting iiwith iiBeta1 iiand ii
Beta2 iireceptors iiin iithe iiheart iiand iilungs ii
, lOMoARcPSD|285 053 80 ii
d. To iilower iiblood iiglucose iiby iistimulating iithe iirelease iiof iiinsulin ii- iia. iiTo iilower
iiblood iipressure iiby iiblocking iithe iiconversion iiof iiangiotensin iiI iito
iivasoconstrictor iiangiotensin iiII ii
ii
5. Which iiof iithe iifollowing iitypes iiof iiinsulin iiis ii"long-acting"? ii
a. Lispro ii(Humalog) ii
b. NPH ii(Humulin iiN) ii
c. Regular iiinsulin ii(Humulin iiR) ii
d. Glargine ii(Lantus) ii- iid. iiGlargine ii(Lantus) ii
6. What iiis iithe iitherapeutic iiuse iiof iimetformin? iiA. iiLower iiblood iipressure. ii
B. To iidiminish iiseizure iiactivity. ii
C. The iimaintenance iiof iia iiperson's iiblood iiglucose. ii
D. Increase iiheart iirate iiand iidecrease iigastrointestinal iisecretions. ii- iiC. iiThe
iimaintenance iiof iia iiperson's iiblood iiglucose. ii
ii
1. What iiis iithe iicorrect iidefinition iifor iiabsorption iiof iia iidrug? ii
A. Movement iiof iidrug iifrom iisite iiof iiadministration iito iivarious iitissues iiof iithe
iibody. ii
B. Describes iithe iiabsorption, iidistribution, iimetabolism ii& iiexcretion iiof iidrugs.
ii
C. These iitypes iiof iidrugs iican iibe iitaken iiover iithe iicounter. ii
D. This iiaddresses iihow iivarious iidrugs iiaffect iidifferent iiforms iiof iithe iibody ii-
iiA. iiMovement iiof iidrug iifrom iisite iiof iiadministration iito iivarious iitissues iiof
iithe iibody ii
ii
2. What iido iiyou iiassess iifor iiin iia iipatient iiwho iiis iion iiValproate? iiSelect iiall iithat
iiapply. ii
A. Suicidal iithoughts ii
B. Monitor iifor iiseizures. ii
C. Bipolar iidisorder. ii
D. Migraines. ii
E. Anorexia ii- iiA. iiSuicidal iithoughts ii
7. B. iiMonitor iifor iiseizures. iiC. iiBipolar iidisorder. iiE. iiMigraines. ii
ii
8. What iiis iitrue iiabout iifood iiand iidrug iiprecautions? iiSelect iiall iithat iiapply. ii
A. You iimust iilimit iicertain iitypes iiof iifood iior iiconcurrent
iiadministration iiof iicertain iitypes iiof iidrugs. ii
B. Certain iicombinations iiof iifood iiand iidrugs iican iicause iiadverse
iireactions. iiC. iiPrecautions iimay iirequire iilimiting iicertain iitypes iiof
iifood iior iiconcurring iidrugs iirather iithan iirestricting iithe iidrug iiitself. ii
C. When iione iidrug iichanges iithe iiway, iianother iidrug iiaffects iithat
iidrug. ii- iiA. iiYou iimust iilimit iicertain iitypes iiof iifood iior iiconcurrent
iiadministration iiof iicertain iitypes iiof iidrugs. ii
B. iiCertain iicombinations iiof iifood iiand iidrugs iican iicause iiadverse iireactions. iiC.
iiPrecautions iimay iirequire iilimiting iicertain iitypes iiof iifood iior iiconcurring iidrugs
iirather iithan iirestricting iithe iidrug iiitself. ii
ii
, lOMoARcPSD|285 053 80 ii
9. ACE iiInhibitors iiare iiused iiin iithe iitreatment iiof iiall iiEXCEPT: ii
a. Hypertension ii
b. Heart iiFailure ii
c. Hypotension ii
d. Diabetic iinephropathy ii- iic. iiHypotension ii
ii
10. Which iiof iithe iifollowing iiis iiused iito iitreat iimigraine iiheadaches? ii
a. Beta-blockers ii
b. Cholinesterase iiInhibitors ii
c. ACE iiinhibitors ii
d. iiAnti-epileptic iidrugs ii(AEDs) ii- iia. iiBeta-blockers ii
ii
11. When iiadministering iia iiSerotonin iiAntagonist iiit iiis iiimportant iito iimonitor iifor ii
a. Intake iiand iioutput ii
b. Mental iistatus iichanges ii
c. Respiratory iirate ii
d. Anorexia ii- iib. iiMental iistatus iichanges ii
ii
12. Which iiof iithe iifollowing iiis iithe iiantidote iifor iiHeparin? ii
a. Protamine iisulfate ii
b. Vitamin iiK ii
c. Naloxone ii
d. Toradol ii- iia. iiProtamine iisulfate ii
ii
13. A iipatient iihas iibeen iitaking iihydrocodone, iiand iiopioid iianalgesic iifor iitheir
iimoderate iipain, iiand iithey iihave iitaken iiover iitheir iiprescribed iidose. iiWhat iishould
iiyou iigive iias iithe iiantidote iiif iithey iiexperience iitoxicity? ii
A. Naloxone ii
B. N-acetylcysteine ii
C. Atropine ii
D. Digoxin iiimmune iiFab ii- iiA. iiNaloxone ii
ii
14.A iiA iipatient iiis iibeing iieducated iion iitaking iilevothyroxine, iia iidrug iiused iito
iibalance iithyroid iiactivity. iiWhat iishould iiyou iiinclude iiin iitheir iieducation? ii
A. Don't iibother iiyour iihealth iicare iiprofessionals iiif iiyou iiexperience
iiside iieffects ii
B. Take iithis iiat iithe iisame iitime iievery iiday ii
C. Thyroid iitests iiare iiunnecessary iiwhile iitaking iithis iidrug ii
D. It iiis iiokay iito iitake iithis iidrug iiif iiyou iihave iirecently iihad iia
iimyocardial iiinfarction ii- iiB. iiTake iithis iiat iithe iisame iitime iievery
iiday ii
ii
15.A iiA iipatient iistates iihe iiexperiences iianxiety iiand iihas iipanic iiattacks iiat iileast iionce
iia iiweek. iiWhat iimight iibe iihelpful iifor iithis iipatient? ii
A. Phenytoin ii(Dilantin) ii
B. Lithium ii
